Evidence map›Paper›PMID 42638123›Full record

ArticleJournal of cheminformatics2026

Computational applications in secondary metabolite discovery (CAiSMD) 2026: focus on secondary metabolites towards drug discovery.

Fidele Ntie-Kang, Jude Y Betow, Donatus B Eni, Jonathan A Metuge, Albisto Adriano, Mary Anti Chama, Hans Denis Bamal, Philippe Belle Ebanda Kedi, Lívia Mendes Campos, Abubakar Sadiq Abdullahi and 20 more

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Fidele Ntie-KangCenter for Drug Discovery, Faculty of Science, University of Buea, Buea, Cameroon. fidele.ntie-kang@ubuea.cm.ORCID http://orcid.org/0000-0003-0795-394X
Jude Y BetowCenter for Drug Discovery, Faculty of Science, University of Buea, Buea, Cameroon.ORCID http://orcid.org/0009-0004-5503-8281
Donatus B EniCenter for Drug Discovery, Faculty of Science, University of Buea, Buea, Cameroon.ORCID http://orcid.org/0000-0002-4148-6372
Jonathan A MetugeDepartment of Natural Resources and Environmental Sciences, Alabama A&M University, Huntsville, AL, USA.ORCID http://orcid.org/0009-0003-9388-895X
Albisto AdrianoBiodiversity and Medicinal Chemistry Group, School of Pharmaceutical Sciences of Ribeirão Preto (FCFRP), Department of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0009-0002-4700-2989
Mary Anti ChamaDepartment of Chemistry, University of Ghana, Accra, Ghana.ORCID http://orcid.org/0000-0002-1072-434X
Hans Denis BamalDepartment of Pharmaceutical Sciences, University of Douala, Douala, Cameroon.ORCID http://orcid.org/0000-0002-2181-5933
Philippe Belle Ebanda KediDepartment of Pharmaceutical Sciences, University of Douala, Douala, Cameroon.ORCID http://orcid.org/0000-0003-4578-0752
Lívia Mendes CamposFaculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.ORCID http://orcid.org/0009-0006-5376-2721
Abubakar Sadiq AbdullahiYoung Researchers Forum of Nigeria, Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, 410001, Enugu State, Nigeria.ORCID http://orcid.org/0000-0002-3896-3844
Gabriel Francisco Filippin MedinaFaculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.
Seraphin B N MbeketDepartment of Chemistry, Faculty of Science, University of Buea, Buea, Cameroon.ORCID http://orcid.org/0000-0002-8885-9324
Yemi A AdekunleDepartment of Pharmaceutical and Medicinal Chemistry, College of Pharmacy, Afe Babalola University, Ado-Ekiti, Nigeria.ORCID http://orcid.org/0000-0002-9392-3925
Alice Rhelly V CarvalhoFaculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.ORCID http://orcid.org/0000-0003-1042-845X
Bruno D A AkambaDepartment of Biochemistry, Faculty of Science, University of Yaoundé I, P. O. Box 812, Yaoundé, Cameroon.ORCID http://orcid.org/0009-0004-3747-6624
Christianah Adebimpe DareDepartment of Biochemistry, Osun State University, Osogbo, Nigeria.ORCID http://orcid.org/0000-0001-8587-9883
Yoshua B MtuloDepartment of Educational Psychology and Curriculum Studies, The University of Dodoma, Dodoma, Tanzania.ORCID http://orcid.org/0009-0003-5751-8070
Edgar López-LópezDepartment of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-7422-6059
Yannick Djoumbou-FeunangCorteva Agriscience, Research, 1862 White Sands Street, CA, United States.ORCID http://orcid.org/0000-0001-7850-184X
Clovis S MetugeCenter for Drug Discovery, Faculty of Science, University of Buea, Buea, Cameroon.ORCID http://orcid.org/0000-0002-5710-6354
Solange NdamoCenter for Drug Discovery, Faculty of Science, University of Buea, Buea, Cameroon.ORCID http://orcid.org/0009-0006-8169-3460
Daniel M ShadrackThe Nelson Mandela African Institute of Science and Technology, P. O. Box 447, Arusha, Tanzania.ORCID http://orcid.org/0000-0002-4436-1487
Bakary N'tji DialloUniversity of Science Techniques and Technologies of Bamako (USTTB), Bamako, Mali.ORCID http://orcid.org/0000-0003-1741-2979
Boris D BekonoDepartment of Physics, Ecole Normale Supérieure, University of Yaounde 1, P. O. Box 47, Yaoundé, Cameroon.ORCID http://orcid.org/0000-0003-1077-4176
Marilia ValliFaculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil.ORCID http://orcid.org/0000-0003-1106-183X
James A MbahDepartment of Chemistry, Faculty of Science, University of Buea, Buea, Cameroon.ORCID http://orcid.org/0000-0003-4208-9819
Saheed SabiuComputational and System Biology Research Group, Department of Biotechnology and Food Science, Durban University of Technology, Durban, South Africa.ORCID http://orcid.org/0000-0001-7209-9220
Samuel A EgieyehSchool of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-7462-6669
José L Medina-FrancoDIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, National Autonomous University of Mexico, 04510, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-4940-1107
Jutta Ludwig-MüllerFaculty of Biology, Technische Universität Dresden, Zellescher Weg 20b, 01062, Dresden, Germany. jutta.ludwig-mueller@tu-dresden.de.ORCID http://orcid.org/0000-0002-9403-5153

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Computational Applications in Secondary Metabolite Discovery (CAiSMD) 2026 workshop was held from 24 to 26 March 2026 in a hybrid format, combining onsite participation at the University of Buea Center for Drug Discovery with global virtual attendance. Building on previous editions, CAiSMD continues to promote the application of bio/cheminformatics and computational chemistry in natural product-based discovery, with a strong emphasis on capacity building for researchers in resource-limited settings.

methodsThe scientific program featured three keynote lectures, seven oral presentations, two hands-on training sessions, two roundtable discussions, and a session dedicated to Young Investigators. Key themes included chemoinformatics resources (databases, webservers, packages, codes, etc.) for natural product research, antimicrobial drug discovery, integrated computational bioprospection, virtual screening, network pharmacology, and multi-target drug design. The hands-on sessions provided practical training in chemical space exploration and virtual screening using the Latin American and African natural products databases.

resultsA major highlight was the Young Investigator session, which showcased innovative research from emerging scientists (MSc students, PhD students, and early postdocs) across diverse therapeutic areas, emphasizing the growing adoption of computational approaches worldwide. Interactive discussions further addressed challenges related to data accessibility, interdisciplinary collaboration, and training needs. Complemented with relevant experimental models, the introduction of bioinformatics, and computational systems biology have accelerated therapeutic innovations through the elimination of time-consuming, expensive, challenging, and inefficient processes that are consistent with the conventional drug discovery systems.

conclusionOverall, CAiSMD2026 successfully combined scientific exchange with practical training, reinforcing the role of computational tools in accelerating secondary metabolite research and empowering young and emerging scientists, particularly in developing countries, to contribute to global drug discovery efforts. SCIENTIFIC CONTRIBUTION: This workshop particpates actively in capacity building fo next generation scientists for the use of computational technologies for secondary metabolite discovery with diverse applications.

Indexed as

Capacity buildingCheminformaticsComputational chemistryDrug discoveryIn silico modelingNatural productsScreening

Identifiers

PMID42638123
PMCPMC13504974

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.